Huang Huiqiang | Medical Oncology | Sun Yat-sen University Cancer Center-Sun Yat-sen University Cancer Center

Name: Huang Huiqiang

Title: Professor, doctoral advisor of Medical Oncology Department

Email: huang_sysu@163.com

Phone:

share

Profile

After receiving a Bachelor’s Degree from former Sun Yat-sen University of Medical Sciences in 1984, Prof. Huang Huiqiang has been engaged himself in clinical work and specializes in common cancer chemotherapy, especially chemotherapy of lymphoma and nasopharynx carcinoma, transplantation of hematopoietic stem cells, recurrent or refractory lymphoma, childhood cancer, germ cell tumor, small cell lung cancer (SCLC) and other tumors in the University. In 2000 and 2004, he went to Fred Hutchinson Cancer Research Center in the US and Australia for short-term studies. Presently, he is the drug evaluation consultant of State Food and Drug Administration (SFDA), and Deputy Director of Lymphoma Committee of Guangdong Province Anti-cancer Association, Deputy Director of Blood Tumor Committee of Guangdong Province Anti-cancer Association and Member of the American Society of Hematology (ASH).

Interests

Education

Publications

The Preliminary Results of Advanced and Recurrent Malignant Lymphoma Treated by BEAC Regimen Supported with Autologous Hematopoietic Stem Cells Transplantation Chinese Huang Hui-qiang et al. Journal of Cancer Research(CJC) 2002 14(1):50-53

Preliminary outcome of rituximab-containing salvage regimens on relapsed or refractory B-cell non-Hodgkin’s lymphoma :single institution experience Bufei Wang ,Huiqiang Huang The Chinese-German Journal of Clinical Oncology 2006 Dec Vol5 Num 6（402）

Phase II clinical trial of Lopaplatin in the treatment of solid malignancies Jiang wen- qi Lin Tong-yi Huang Hui-qiang et al : International Journal of Modern Cancer Therapy 1999，33:312-5

Novantrone:A phase II trial in the treatment of advanced nasopharyngeal carcinoma in the People’s Republic of China Z.Z. Guan, H.Q. Huang , R. Rastogi Proceedings of American Society of Clinical Oncology(ASCO) 1993 : 12 (5) abstract 922

Updated by International Office, Sun Yat-sen University Cancer Center

Our Experts